📰 James Hackworth News
James Hackworth News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from James Hackworth. Real-time updates on events, politics, business and more.
April 18, 2024
Tris Pharma has formed the organization along with a licensing agreement with Braingaze for development, distribution of the technology.
December 7, 2022
/PRNewswire/ -- Tris Pharma, Inc. ("Tris"), a fully integrated, innovation-driven CNS company with a robust portfolio of FDA-approved products for the...
August 16, 2022
/PRNewswire/ -- Tris Pharma, Inc. (Tris) a fully integrated pharmaceutical company with a robust portfolio of CNS products announced today that DYANAVEL® XR...
November 5, 2021
/PRNewswire/ -- Tris Pharma, Inc. (Tris) announced today that the U.S. Food and Drug Administration has approved Dyanavel XR (amphetamine), extended release...
April 29, 2021
Share this article Share this article MONMOUTH JUNCTION, N.J., April 29, 2021 /PRNewswire/ -- Tris Pharma, Inc. ("Tris"), a specialty pharmaceutical company with a robust portfolio of approved products and a late-stage pipeline of innovative product candidates for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and related conditions, today announced that it has acquired Park Therapeutics, a company developing a unique, first-in-class, investigational NCE for the treatment of ...